Variant report
Variant | esv3358179 |
---|---|
Chromosome Location | chr8:85259847-85270795 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:85254893..85257135-chr8:85258246..85262364,3 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs574787690 | chr8:85263200-85263201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs540622929 | chr8:85263211-85263212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs560776619 | chr8:85263223-85263224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs577565439 | chr8:85263237-85263238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs374518777 | chr8:85263238-85263239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs562905133 | chr8:85263278-85263279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs181468714 | chr8:85263317-85263318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs548006581 | chr8:85263352-85263353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150517504 | chr8:85263371-85263372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs527335364 | chr8:85263394-85263395 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530270266 | chr8:85263398-85263399 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs558615754 | chr8:85263418-85263419 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs184546536 | chr8:85263468-85263469 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs539315603 | chr8:85263484-85263485 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs576905800 | chr8:85263497-85263498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs138312628 | chr8:85263531-85263532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs72679306 | chr8:85263570-85263571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs368238024 | chr8:85264043-85264044 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs149644687 | chr8:85264048-85264049 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs116150612 | chr8:85264072-85264073 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs569293961 | chr8:85264110-85264111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs561635082 | chr8:85264187-85264188 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs568482058 | chr8:85264651-85264652 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs534251504 | chr8:85264675-85264676 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs554291301 | chr8:85264689-85264690 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs182082985 | chr8:85264716-85264717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs539836955 | chr8:85264722-85264723 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs76138515 | chr8:85264745-85264746 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146329947 | chr8:85264761-85264762 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542081711 | chr8:85264780-85264781 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs187631557 | chr8:85264812-85264813 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs572292216 | chr8:85264831-85264832 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs117497169 | chr8:85264946-85264947 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs563835935 | chr8:85264979-85264980 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs71522959 | chr8:85264982-85264983 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs532806315 | chr8:85265013-85265014 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs191985001 | chr8:85265023-85265024 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs4740009 | chr8:85265029-85265030 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
39 | rs182794277 | chr8:85265075-85265076 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs548920759 | chr8:85265085-85265086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs139642019 | chr8:85265086-85265087 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs534241010 | chr8:85265109-85265110 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs546826378 | chr8:85265116-85265117 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs555510108 | chr8:85265125-85265126 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs568263248 | chr8:85265216-85265217 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs547955962 | chr8:85265219-85265220 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs372570785 | chr8:85265220-85265221 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs539848478 | chr8:85265255-85265256 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs142772906 | chr8:85265312-85265313 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs570271358 | chr8:85265358-85265359 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Prostate cancer | 16461572 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Breast cancer | 17393978 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Bladder cancer | 19088036 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 17899364 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Epilepsy | 20502679 | CNVD |
Acute monocytic leukemia | 16498392 | CNVD |
Autism | 20841430 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:85263200-85263600 | Enhancers | Brain Germinal Matrix | brain |
2 | chr8:85264000-85264200 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
3 | chr8:85264000-85264200 | Enhancers | Brain Germinal Matrix | brain |
4 | chr8:85264600-85265800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
5 | chr8:85264800-85265000 | Enhancers | HUES6 Cell Line | embryonic stem cell |
6 | chr8:85265000-85265600 | Weak transcription | HUES6 Cell Line | embryonic stem cell |
7 | chr8:85265400-85267200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
8 | chr8:85265600-85266000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
9 | chr8:85265600-85266600 | Enhancers | NH-A | brain |
10 | chr8:85265600-85266800 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
11 | chr8:85265600-85266800 | Enhancers | HUES64 Cell Line | embryonic stem cell |
12 | chr8:85265600-85267400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
13 | chr8:85265600-85267600 | Enhancers | HUES48 Cell Line | embryonic stem cell |
14 | chr8:85265600-85267800 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
15 | chr8:85265600-85268200 | Enhancers | HUES6 Cell Line | embryonic stem cell |
16 | chr8:85265800-85266800 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
17 | chr8:85265800-85267000 | Enhancers | Foreskin Melanocyte Primary Cells skin03 | Skin |
18 | chr8:85265800-85267200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
19 | chr8:85265800-85267400 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
20 | chr8:85266400-85268200 | Enhancers | H1 Cell Line | embryonic stem cell |
21 | chr8:85267200-85268200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
22 | chr8:85267200-85272200 | Weak transcription | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
23 | chr8:85268200-85268400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |